Drug factory · FDA FEI 1021259
Microbac Laboratories, Inc.
3809 Airport Drive NW, Wilson, NC, United States
Problems found, fixed voluntarily at FDA's last inspection, Sep 3, 2026.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
6 drug inspections on record since 2010: 4 with no problems, 2 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Aprepitant | Tests it | Spes Pharmaceuticals Inc. | 82243-1001 |
| Lanthanum Cation (3+) | Tests it | Prasco Laboratories, Takeda Pharmaceuticals America, Inc. | 66993-422, 66993-423, 66993-424 +5 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Sep 3, 2026 | Problems found, fixed voluntarily | Drug Quality Assurance | 1 |
| Dec 6, 2023 | No problems found | Drug Quality Assurance | — |
| Feb 22, 2018 | No problems found | Drug Quality Assurance | — |
| Jul 9, 2015 | No problems found | Drug Quality Assurance | — |
| Apr 26, 2012 | No problems found | Drug Quality Assurance | — |
| Feb 23, 2010 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
What inspectors wrote down
From FDA's Form 483 citations: conditions an investigator observed that may violate drug manufacturing rules, as FDA published them.
Sep 3, 2026 inspection
- Written record of investigation incomplete 21 CFR 211.192
Written records of investigations into unexplained discrepancies do not always include the conclusions and follow-up.
Registered with FDA for: analysis.